Stereotaxis (STXS)
(Real Time Quote from BATS)
$2.33 USD
-0.05 (-2.10%)
Updated Apr 25, 2024 10:18 AM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Price, Consensus and EPS Surprise
STXS 2.33 -0.05(-2.10%)
Will STXS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for STXS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for STXS
Stereotaxis (STXS) Seeks Clearance for MAGiC Catheter
Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates
STXS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Penumbra (PEN) Q4 Earnings Beat Estimates
AxoGen (AXGN) Moves 6.8% Higher: Will This Strength Last?
Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates
Other News for STXS
Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
7 Penny Stocks That Could 5X by the End of 2024
Canopy Growth, Exact Sciences, Stereotaxis among healthcare movers
Stereotaxis management to meet with Lake Street